Transcend Capital Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Transcend Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$209.01 - $232.56 $19,019 - $21,162	91 Added 6.96%	1,398 $305,000
Q4 2023 Feb 05, 2024	SELL	$197.69 - $227.29 $42,107 - $48,412	-213 Reduced 14.01%	1,307 $297,000
Q3 2023 Oct 31, 2023	BUY	$201.05 - $221.7 $5,629 - $6,207	28 Added 1.88%	1,520 $305,000
Q2 2023 Jul 13, 2023	BUY	$211.93 - $241.33 $19,497 - $22,202	92 Added 6.57%	1,492 $360,000
Q1 2023 Apr 12, 2023	BUY	$213.32 - $257.83 $298,648 - $360,962	1,400 New	1,400 $321,000
Q3 2022 Oct 17, 2022	BUY	$204.81 - $262.19 $95,441 - $122,180	466 Added 41.98%	1,576 $323,000
Q2 2022 Jul 12, 2022	BUY	$213.86 - $277.87 $10,479 - $13,615	49 Added 4.62%	1,110 $260,000
Q1 2022 Apr 20, 2022	BUY	$259.82 - $298.18 $275,669 - $316,368	1,061 New	1,061 $280,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Transcend Capital Advisors, LLC with notifications on news.